Antibody Therapeutics for Life

Press Release

PharmAbcine,BioPharma Dealmakers_sep 2019
  • Written by PharmAbcine
  • Written date 2019-10-01 10:11:00
  • Inquire 12041
Attachments BPDm September 2019_PharmAbcine.pdf

PharmAbcine, a clinical stage immune-oncology company, today announced that PharmAbcine was 

introduced at Biopharma dealmakers on September edition.

Please check the attached file for details.


Prev PharmAbcine, Drug Discovery Special APAC 2019
Next PharmAbcine, Olinvacimb, able to manage the first recruitment of patients for p...